The results were consistent with those in tumor cells, where ERp29 upregulated miR-135a-5p expression and downregulated levels of IL-1β and active form of caspase-1 (Fig. 6B and H), suggesting that this mechanism is generalized but not cancer specific. The gene discussed is ERP29; the disease is neoplasm.